Regulatory Genome provides machine-readable regulatory content to increase accessibility and dissemination of information.
Regulatory Genome has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Regulatory Genome's investors include Mastercard, Evolution Equity Partners, AlbionVC, University of Cambridge Enterprise.
Regulatory Genome is headquartered in Cambridge, United Kingdom.
Regulatory Genome provides machine-readable regulatory content to increase accessibility and dissemination of information.
Regulatory Genome is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regulatory Genome — Funding & Investors." VCBacked, April 11, 2022, https://www.vcbacked.co/company/regulatory-genome. Accessed August 14, 2026.
VCBacked. (2022). Regulatory Genome — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/regulatory-genome
{{cite web |title=Regulatory Genome — Funding & Investors |url=https://www.vcbacked.co/company/regulatory-genome |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated